Next Generation Sequencing Market to grow at a CAGR of approximately 20%.

Research Trades adds a new report package “Next Generation Sequencing Market- Size, Share, Trends, Forecast”

The Global market for Next Generation Sequencing is poised to reach $10 billion by December 2020, growing at a CAGR of approximately 20%. The Instruments & Consumables is the largest segment with a share of around half of the market in 2013. The fastest growing segment is the services with a highest CAGR during the forecast period. Industry players are interested in services segment as it provides additional revenue for the company while increasing the sales of instruments and reagents. The major players operating in the NGS market are Illumina Inc. (U.S.), Thermo Fisher Scientific (U.S.), Hoffmann-La Roche Ltd (Switzerland), Pacific Biosciences (U.S.) Agilent Technologies (U.S.), BGI (Beijing Genomics Institute) (China), Qiagen (Netherlands), Biomatters Ltd (New Zealand), and Genomatix Software GmbH (Germany).

Get Sample copy of this report @ https://www.researchtrades.com/request-sample/1090960

North America is currently the largest market for NGS. This is due to the increased awareness about the quick return of investments and accuracy. Asia-Pacific is one of the fastest growing segments. The NGS market can be segmented on the basis of Technology: Whole Genome Sequencing, Targeted Resequencing, Whole Exome Sequencing, RNA Sequencing, Chip Sequencing, De Novo Sequencing and Methyl Sequencing; Products: Instruments, Reagents & Consumables, and Services; End user: Hospitals & Healthcare Institutions, Academics, Biotech & Pharma Firms, and Others; Applications: Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture & Animal Research, Infectious Diseases among others; Geography: North America, Europe, APAC & RoW.

Increasing applications in clinical diagnosis boosting the market growth, speed, cost and accuracy to spur the market growth, efficient replacement for traditional technologies (Microarrays), and drug discovery applications demanding NGS technology are the major factors driving the growth of the market.

Legal & ethical issues to hamper the market growth, interpretation of complex data, and lack of skilled professionals are the major restraints that are hampering the NGS market growth.

Key Chapters of this report are:
1. Introduction
1.1 Report Description
1.2 Research Methodology
2. Executive Summary
3. Market Overview
3.1 Market Definition
3.2 Market Drivers
3.2.1 Increasing Applications In The Clinical Diagnosis
3.2.2 Speed, Cost And Accuracy To Spur The Market Growth
3.2.3 Efficient Replacement For Traditional Technologies (Microarrays)
3.2.4 Drug Discovery Applications Demanding Ngs Technology
3.3 Market Restraints
3.3.1 Legal And Ethical Issues
3.3.2 Interpretation Of Complex Data
3.3.3 Lack Of Skilled Professionals
4. Porter?S Five Forces
4.1 Bargaining Power Of Suppliers
4.2 Bargaining Power Of Buyers
4.3 Degree Of Competition:
4.4 Threat Of Substitution:
4.5 Threat Of New Entrants:
5. Global Market Segmentation
6. Competitive Landscape
6.1 Mergers And Acquisitions
6.2 Agreements, Collaborations & Partnerships
6.3 New Product Launches

View Complete Report @ https://www.researchtrades.com/report/global-next-generation-sequencing-market-by-technology-products-end-users-and-applications-industry-analysis-size-share-growth-trends-and-forecasts-2016-2021/1090960

About Research Trades:
Research Trades has team of experts who works on providing exhaustive analysis pertaining to market research on a global basis. This comprehensive analysis is obtained by a thorough research and study of the ongoing trends and provides predictive data regarding the future estimations, which can be utilized by various organizations for growth purposes.

Contact us:
Email: sales@researchtrades.com
Call us: +1 6269994607 / +91 7507349866
Skype ID: researchtradescon
Web: www.researchtrades.com

This release was published on openPR.